Tri-Lo- Estarylla
These highlights do not include all the information needed to use Tri-Lo-Estarylla safely and effectively. See full prescribing information for Tri-Lo-Estarylla. Tri-Lo-Estarylla (norgestimate and ethinyl estradiol tablets) for oral useInitial U.S. Approval: 1989
Approved
Approval ID
8381db98-f9b2-e894-c07e-5d49f10e4eea
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 21, 2023
Manufacturers
FDA
Xiromed, LLC.
DUNS: 080228637
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
norgestimate and ethinyl estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code70700-120
Application NumberANDA091232
Product Classification
M
Marketing Category
C73584
G
Generic Name
norgestimate and ethinyl estradiol
Product Specifications
Effective DateDecember 21, 2023
FDA Product Classification